Xtx Topco LTD Ocular Therapeutix, Inc Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$2.08 - $4.52 $58,119 - $126,297	27,942 New	27,942 $124,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $481,766 - $814,019	184,585 Added 353.16%	236,851 $665,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $121,464 - $193,037	29,698 Added 131.59%	52,266 $217,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $39,728 - $68,898	-13,199 Reduced 36.9%	22,568 $91,000
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $113,901 - $173,327	23,582 Added 193.53%	35,767 $177,000

Q4 2021 Feb 11, 2022	BUY	$6.16 - $12.07 $75,059 - $147,072	12,185 New	12,185 $85,000
Q3 2021 Nov 12, 2021	SELL	$9.7 - $14.34 $224,273 - $331,555	-23,121 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$13.43 - $19.16 $310,515 - $442,998	23,121 New	23,121 $328,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.